Related Experiment Video
Updated: Jan 11, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
Chromogranin A promotes the pathological conversion of α-synuclein at the synapse in Parkinson's disease
Yu Liu1, Weixian Kong2, Feipeng Zhu3
1Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China.
Abstract:
α-Synuclein (αSyn) aggregation is a prominent hallmark of Parkinson's disease (PD), yet the initial cellular mechanisms are not well understood. In this study, we show that a single day of αSyn preformed fibril (PFF) administration leads to prominent localization of phosphorylated αSyn (p-αSyn) within the pre-synapse of primary neurons. Overexpressing chromogranin A (CgA), which is found in large dense-core vesicles (LDCVs), enhances αSyn aggregation in various neuronal and PD mouse models. Subsequently, by incubating αSyn with CgA, we create a unique strain of fibrils displaying smaller length, stronger resistance to proteolytic digestion, and higher amyloidogenic properties compared to conventional αSyn fibrils. Additionally, CgA knockout alleviates dendritic spine loss and synaptic dysfunction induced by αSyn PFF and slows down the spread of pathological inclusions in vivo. Collectively, our findings demonstrate how the intra-vesicular matrix protein CgA triggers and facilitates early seeding events leading to subsequent toxicity caused by αSyn pathology.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drugs Affecting Neurotransmitter Synthesis